OBJECTIVE: Major depressive disorder (MDD) has been associated with executive dysfunction and related abnormal prefrontal activity, whereas the status of executive function (EF) in frequently co-occurring anxiety disorders and in comorbid depression-anxiety is unclear. We aimed to study functional MRI correlates of (visuospatial) planning in MDD and anxiety disorders and to test for the effects of their comorbidity. METHOD: Functional MRI was employed during performance of a parametric Tower of London task in out-patients with MDD (n = 65), MDD with comorbid anxiety (n = 82) or anxiety disorders without MDD (n = 64), and controls (n = 63). RESULTS: Moderately/severely depressed patients with MDD showed increased left dorsolateral prefrontal activity as a function of task load, together with subtle slowing during task execution. In mildly depressed and remitted MDD patients, in anxiety patients, and in patients with comorbid depression-anxiety, task performance was normal and no activation differences were observed. Medication use and regional brain volume were not associated with altered visuospatial planning. CONCLUSION: Prefrontal hyperactivation during high planning demands is not a trait characteristic, but a state characteristic of MDD without comorbid anxiety, occurring independent of SSRI use. Disturbances in planning or the related activation are probably not a feature of anxiety disorders with or without comorbid MDD, supporting the current distinction between anxiety disorders and depression.
OBJECTIVE: Major depressive disorder (MDD) has been associated with executive dysfunction and related abnormal prefrontal activity, whereas the status of executive function (EF) in frequently co-occurring anxiety disorders and in comorbid depression-anxiety is unclear. We aimed to study functional MRI correlates of (visuospatial) planning in MDD and anxiety disorders and to test for the effects of their comorbidity. METHOD: Functional MRI was employed during performance of a parametric Tower of London task in out-patients with MDD (n = 65), MDD with comorbid anxiety (n = 82) or anxiety disorders without MDD (n = 64), and controls (n = 63). RESULTS: Moderately/severely depressedpatients with MDD showed increased left dorsolateral prefrontal activity as a function of task load, together with subtle slowing during task execution. In mildly depressed and remitted MDDpatients, in anxietypatients, and in patients with comorbid depression-anxiety, task performance was normal and no activation differences were observed. Medication use and regional brain volume were not associated with altered visuospatial planning. CONCLUSION: Prefrontal hyperactivation during high planning demands is not a trait characteristic, but a state characteristic of MDD without comorbid anxiety, occurring independent of SSRI use. Disturbances in planning or the related activation are probably not a feature of anxiety disorders with or without comorbid MDD, supporting the current distinction between anxiety disorders and depression.
Authors: Julia I Herzog; Inga Niedtfeld; Sophie Rausch; Janine Thome; Meike Mueller-Engelmann; Regina Steil; Kathlen Priebe; Martin Bohus; Christian Schmahl Journal: Eur Arch Psychiatry Clin Neurosci Date: 2017-07-15 Impact factor: 5.270
Authors: Rebecca B Price; Kathleen Gates; Thomas E Kraynak; Michael E Thase; Greg J Siegle Journal: Neuropsychopharmacology Date: 2017-05-12 Impact factor: 7.853
Authors: Saskia Woudstra; Marie-José van Tol; Zoltán Bochdanovits; Nic J van der Wee; Frans G Zitman; Mark A van Buchem; Esther M Opmeer; André Aleman; Brenda W Penninx; Dick J Veltman; Witte J Hoogendijk Journal: PLoS One Date: 2013-04-19 Impact factor: 3.240
Authors: Lianne Schmaal; Andre F Marquand; Didi Rhebergen; Marie-José van Tol; Henricus G Ruhé; Nic J A van der Wee; Dick J Veltman; Brenda W J H Penninx Journal: Biol Psychiatry Date: 2014-11-29 Impact factor: 13.382
Authors: Marie-José van Tol; Ilya M Veer; Nic J A van der Wee; André Aleman; Mark A van Buchem; Serge A R B Rombouts; Frans G Zitman; Dick J Veltman; Tom Johnstone Journal: Neuroimage Clin Date: 2013-06-13 Impact factor: 4.881
Authors: S Woudstra; Z Bochdanovits; M-J van Tol; D J Veltman; F G Zitman; M A van Buchem; N J van der Wee; E M Opmeer; L R Demenescu; A Aleman; B W Penninx; W J Hoogendijk Journal: Transl Psychiatry Date: 2012-04-03 Impact factor: 6.222